Loading stock data...

Vasundhara Rasayans Limited

BSE: VRL

BSE
175.05 -4.45 (-2.48%)

Prev Close

179.5

Open Price

184.45

Volume

2,273

Today Low / High

174.1 / 184.45

52 WK Low / High

170 / 330

Range

166 - 184

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 175.05, reflecting a change of -4.45 (-2.47911%). The expected target range on the BSE is 166 - 184. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

01 Oct 184.45 -5.10%
30 Sep 185.00 -2.97%
29 Sep 182.30 -1.29%
26 Sep 187.10 -2.19%
25 Sep 186.15 0.99%
24 Sep 194.45 -4.73%
23 Sep 191.00 -2.28%
22 Sep 201.00 -4.50%
19 Sep 185.20 7.13%
18 Sep 186.20 2.79%
17 Sep 198.80 -5.89%
16 Sep 204.00 -8.53%
15 Sep 199.50 -5.09%
12 Sep 188.95 3.84%
11 Sep 202.60 -6.74%
10 Sep 175.40 7.64%
09 Sep 172.85 1.48%
08 Sep 175.00 2.17%
05 Sep 172.20 0.78%
04 Sep 180.00 -3.25%
03 Sep 175.50 3.59%

Vasundhara Rasayans Limited Graph

Vasundhara Rasayans Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Vasundhara Rasayans Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 175.05, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 175.05 176.80 159.12 - 194.48
178.55 142.84 - 214.26
180.30 126.21 - 234.39
Bearish Scenario 175.05 173.30 155.97 - 190.63
171.55 137.24 - 205.86
169.80 118.86 - 220.74

Overview of Vasundhara Rasayans Limited

ISIN

INE406F01010

Industry

Medical - Pharmaceuticals

Vol.Avg

1,190

Market Cap

556,343,910

Last Dividend

2

Official Website

Visit Website

IPO Date

2015-01-13

DCF Diff

145.72

DCF

29

Financial Ratios Every Investor Needs

Stock Dividend of VRL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 2 2 2025-09-19 2025-10-26
2024-09-23 September 23, 24 2 2 2024-09-23 2024-09-30
2023-08-22 August 22, 23 2 2 2023-08-22 2023-09-28
2022-09-23 September 23, 22 1 1 2022-09-23 2022-10-30
2021-09-22 September 22, 21 1.5 1.5 2021-09-23 2021-10-30

Stock Rating Details for VRL

Metric Value Recommendation
Overall Rating C Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 33.99 Cr 15.48 Cr 18.52 Cr 0.5447 0.00 Cr 0.00 Cr 3.69 Cr 4.25 Cr 13.36 6.39 Cr 0.1249
2024-03-31 37.02 Cr 21.91 Cr 15.11 Cr 0.4081 0.00 Cr 2.41 Cr 6.13 Cr 5.86 Cr 18.44 6.39 Cr 0.1583
2023-03-31 37.94 Cr 24.61 Cr 13.33 Cr 0.3514 0.00 Cr 1.93 Cr 5.43 Cr 5.59 Cr 17.59 5.54 Cr 0.1474
2022-03-31 26.75 Cr 18.72 Cr 8.03 Cr 0.3001 0.00 Cr 2.05 Cr 2.09 Cr 2.17 Cr 6.84 2.22 Cr 0.0812
2021-03-31 22.68 Cr 13.05 Cr 9.63 Cr 0.4246 0.00 Cr 1.71 Cr 3.06 Cr 2.94 Cr 9.24 3.16 Cr 0.1294

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 5.54 Cr 43.07 Cr 7.51 Cr 35.5585 Cr 4.21 Cr -1.34 Cr 1.88 Cr 2.49 Cr 0.00 Cr 0.00 Cr 2.35 Cr 7.4328 Cr
2024-03-31 9.56 Cr 37.30 Cr 5.36 Cr 31.9383 Cr 1.95 Cr -7.62 Cr 1.73 Cr 2.43 Cr 0.00 Cr 0.00 Cr -1.11 Cr 4.4947 Cr
2023-03-31 7.74 Cr 34.52 Cr 7.70 Cr 26.8185 Cr 4.02 Cr -3.72 Cr 4.00 Cr 0.86 Cr 0.00 Cr 0.00 Cr 0.13 Cr 7.6687 Cr
2022-03-31 10.77 Cr 25.50 Cr 3.97 Cr 21.5367 Cr 1.31 Cr -9.46 Cr 2.21 Cr 0.91 Cr 0.00 Cr 0.00 Cr -0.16 Cr 3.9306 Cr
2021-03-31 0.69 Cr 23.01 Cr 3.14 Cr 19.8708 Cr 0.00 Cr -0.69 Cr 1.41 Cr 0.67 Cr 0.00 Cr 0.00 Cr 0.00 Cr 2.6294 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -5.8346 Cr 0.4595 Cr 1.3547 Cr -6.2537 Cr -4.0204 Cr 5.5414 Cr -0.4191 Cr 5.7673 Cr 2.2596 Cr -0.6356 Cr -0.1436 Cr
2024-03-31 6.0299 Cr -1.3216 Cr -2.8826 Cr 4.1989 Cr 1.8257 Cr 9.5618 Cr -1.8310 Cr 5.8593 Cr -2.0731 Cr -0.6356 Cr 2.2649 Cr
2023-03-31 -6.5010 Cr 1.2723 Cr 2.1917 Cr -6.5821 Cr -3.0370 Cr 7.7361 Cr -0.0811 Cr 7.4757 Cr 2.7090 Cr -0.3178 Cr -1.7865 Cr
2022-03-31 7.9044 Cr 1.3887 Cr 0.7894 Cr 7.5507 Cr 10.0825 Cr 10.7731 Cr -0.3537 Cr 3.0464 Cr 1.3106 Cr -0.4767 Cr -0.8062 Cr
2021-03-31 0.2166 Cr 0.1565 Cr -0.4922 Cr -0.2082 Cr -0.1191 Cr 0.6906 Cr -0.4248 Cr 3.9619 Cr 0.0000 Cr -0.4767 Cr 0.0895 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 7.56 Cr 3.60 Cr 3.96 Cr 0.5243 0.23 Cr 0.57 Cr 1.80 1.01 Cr 0.0758
2025-03-31 7.76 Cr 4.78 Cr 2.97 Cr 0.3835 -0.19 Cr 0.39 Cr 1.23 0.74 Cr 0.0504
2024-12-31 8.82 Cr 3.67 Cr 5.15 Cr 0.5839 1.48 Cr 1.45 Cr 4.57 2.11 Cr 0.1647
2024-09-30 9.78 Cr 3.76 Cr 6.02 Cr 0.6155 1.53 Cr 1.47 Cr 4.61 2.14 Cr 0.1498
2024-06-30 7.63 Cr 3.26 Cr 4.37 Cr 0.5725 0.77 Cr 0.86 Cr 2.71 1.30 Cr 0.1129

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 5.54 Cr 0.18 Cr 5.73 Cr 28.61 Cr 1.88 Cr 38.23 Cr 2.49 Cr 43.07 Cr 7.51 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.75 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -37.02 Cr
2024-09-30 1.75 Cr 0.00 Cr 1.75 Cr 24.65 Cr 2.16 Cr 32.50 Cr 2.29 Cr 44.02 Cr 7.00 Cr
2024-06-30 0.00 Cr 0.00 Cr 10.72 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -31.94 Cr
2024-03-31 9.56 Cr 1.16 Cr 10.72 Cr 6.22 Cr 1.73 Cr 34.83 Cr 2.43 Cr 37.30 Cr 5.36 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 1.45 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.47 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.86 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 2.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 1.38 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹741.80 ₹88,825,874,435.00 ₹95,115.00

Key Executives

Company Secretary & Compliance Officer
Mr. Santosh Kumar Jha

Gender: male

Year Born:

Chief Financial Officer & Whole Time Director
Mr. Sunil Kumar Jain

Gender: male

Year Born: 1962

MD & Whole Time Director
Mr. Rajesh Pokerna

Gender: male

Year Born: 1965

Whole Time Director
Mr. Sanjay Kumar Jain

Gender: male

Year Born: 1967

Whole-time Women Director
Ms. Seema Jain

Gender: female

Year Born: 1970

FAQs about Vasundhara Rasayans Limited

Who is the CEO of the company?

The CEO is Rajesh Pokerna.

What is the current market price of the stock?

The current price is ₹175.05.

What is the 52-week price range?

The range is ₹170-330.

What is the market capitalization of the company?

The market capitalization is ₹55.63 crores.

What is the dividend yield?

The dividend yield is 1.14%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 14.35.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Vasundhara Rasayans Limited (ISIN: INE406F01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹55.63 crores and an average daily volume of 1,190 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹2.